Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success
News | Heart Failure
FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial

August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...

Home August 29, 2022
Home
Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success
News | Implantable Cardioverter Defibrillator (ICD)
Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

Home August 29, 2022
Home
Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients with a history of smoking. 
News | ESC
New REDUCE-IT Data Released at ESC Oral Presentation Session

August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) ...

Home August 29, 2022
Home
A study from the Smidt Heart Institute and Cedars-Sinai's Division of Artificial Intelligence in Medicine shows that AI was more accurate in diagnosing cardiac function than sonographers. Illustration by Getty.
News | Artificial Intelligence
Late-Breaking Heart Research: AI More Accurate Than Technicians

August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...

Home August 29, 2022
Home
The USPSTF has issued a Recommendation Statement, relating to Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
News | Cardiovascular Education
USPSTF Issues Statin Recommendation Statement

August 29, 2022 — ­The US Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to ...

Home August 29, 2022
Home
COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, according to research presented at ESC Congress 2022.
News | Coronavirus (COVID-19)
COVID mRNA Vaccines are Safe in Patients with Heart Failure

August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...

Home August 26, 2022
Home
A new Cedars-Sinai study is the first study proven to be effective at identifying coronary artery disease patients at highest risk for sudden cardiac death. Photo by Cedars-Sinai.
News | Sudden Cardiac Arrest
Genetic Score Detects Those at Risk for Sudden Cardiac Death

August 26, 2022 — Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients ...

Home August 26, 2022
Home
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program is now available for the TCT MedTech Innovation Forum.
News | TCT
CRF and Fogarty Innovation Announce Agenda for TCT MedTech Innovation Forum

August 26, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program ...

Home August 26, 2022
Home
Jamshid Maddahi, MD, FASNC
News | PET Imaging
Late Breaking Flurpiridaz Trial Results at ASNC2022

August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...

Home August 25, 2022
Home
Imperfect current propagation in the heart is at the root of most cardiac diseases
News | Cardiac Imaging
Measuring Currents in the Heart at Millimeter Resolution with a Diamond Quantum Sensor

August 25, 2022 — Imperfect current propagation in the heart is at the root of most cardiac diseases. Thanks to a novel ...

Home August 25, 2022
Home
Independent Data Presented at the World Federation of Interventional and Therapeutic Neuroradiology 2022 Annual Meeting Highlights the Benefits of Vessel-Matching with Zoom Reperfusion Catheters
News | Stroke
Imperative Care Announces Positive New Data Underscoring the Safety and Efficacy of the Zoom Stroke Solution to Treat Distal Occlusions in Ischemic Stroke Patients

August 25, 2022 — Imperative Care, Inc. announced that new data evaluating the utility of the Zoom Stroke Solution were ...

Home August 25, 2022
Home
The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling HeartWare HVAD System batteries because the batteries may experience electrical faults that cause them to unexpectedly fail.
News | Ventricular Assist Devices (VAD)
Medtronic Recalls HeartWare HVAD System Batteries for Electrical Faults That Cause Battery Failure

August 25, 2022 — The U.S. Food and Drug Administration (FDA) issued a statement that Medtronic, Inc. is recalling ...

Home August 25, 2022
Home
Dr. Jonathan Roberts is medical director of Clinical Research and Education, Interventional Cardiology for Memorial Healthcare System and program director of its Cardiology Fellowship program.
News | Heart Failure
Congestive Heart Failure Patients May Be Eligible for Treatment that Could Help Them Live Longer

August 24, 2022 — Patients diagnosed with moderate aortic stenosis and congestive heart failure may qualify to ...

Home August 24, 2022
Home
Screen Shot 2022-08-19 at 10.46.20 AM
News | Stroke
iHealthScreen Inc. Introduces An Automated Stroke Prediction Model, based on AI and Color Fundus Imaging

August 24, 2022 — iPredict late stroke prediction model provides a fully automated prediction score for incident stroke ...

Home August 24, 2022
Home
A study simulating a population of 30 million people 65 and older found that wrist-wearable devices are more cost-effective than traditional electrocardiograms and pulse palpation for atrial fibrillation (AF) screening, and that they are associated with a reduction in stroke incidence
News | Wearables
Wrist-Worn Devices are Shown by Mass General Researchers to be Cost-Effective for Screening of Atrial Fibrillation

August 24, 2022 — Screening individuals for atrial fibrillation (AF) using wearable devices is more cost-effective than ...

Home August 24, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now